Detailed Information

SNP ID FP0000130 Gene Symbol ABCG2 Chromosome 4q22 Original ID MPJ6_AG2007 rs5860119 Site Intron 3 Reference Sequence NT_016354.17 Position 1 13548362_13548361 Position 2 46767_46768 Position 3 7768291_7768290 Position 4 IVS3+71_+72 Obserbed -/T 5'-Flanking TAAGCGTTTTCTGTGCACTTTTAATGTGCTTTTAAAAGCCACTTTTTTTT 3'-Flanking GTGTGCGAGCAGGTATTTATTGAGCATTTGCAACGCATGTCAGGTCTGGT Effect Frequency 3/354 Method Sequencing 1st Forward Primer ABCG2-3F TGGTTTGTGCTTGTGTTCTA 1st Reverse Primer ABCG2-3R GCTCAATAAATACCTGCTCG SQ Forward Primer ABCG2-3F1 GGTTTGTGCTTGTGTTCTAT SQ Reverse Primer ABCG2-3R GCTCAATAAATACCTGCTCG Reference 1 Itoda et al., 2003, Drug Metab. Pharmacokinet., 18, 212-217. Reference 2 Maekawa et al., 2006, Drug Metab. Pharmacokinet., 21, 109-121. Haplotype Block 1 *1g Comment 1 Position 2: Reference sequence is AC084732. Position 3: Reference sequence is NT_006204.13. Position 4: cDNA-based numbering. Comment 2 Frequency and haplotype: Reference 2. Release Date 2003/05/09 Update Date 2006/01/07

---

SQ=Sequencing; TP=Typing; IVS=Intervening Sequence; CYPalleles, http://www.imm.ki.se/CYPalleles/ .